Inhibition of growth and increased expression of insulin-like growth factor-binding protein-3 (IGFBP-3) and-6 in prostate cancer cells stably transfected with antisense IGFBP-4 complementary deoxyribonucleic acid
Rh. Drivdahl et al., Inhibition of growth and increased expression of insulin-like growth factor-binding protein-3 (IGFBP-3) and-6 in prostate cancer cells stably transfected with antisense IGFBP-4 complementary deoxyribonucleic acid, ENDOCRINOL, 142(5), 2001, pp. 1990-1998
Insulin-like growth factor-binding proteins (IGFBPs) both stimulate and inh
ibit IGF activity, and in the M12 prostate cancer cell line, overexpression
of IGFBP-4 was shown to delay tumorigenesis while decreasing the productio
n of IGFBP-2. We have performed the reverse experiment, inhibition of IGFBP
-4 expression with antisense complementary DNA, in two prostate tumor cell
lines, ALVA-31 and M12. Expression of antisense messenger RNA transcripts w
as verified by RNase protection assays, and inhibition of mature IGFBP-4 in
cell medium was demonstrated by Western blotting. Both transfected lines (
ALVA-31asBP4 and M12asBP4) proliferated more slowly in monolayer culture th
an parental controls. Colony formation in soft agar was strongly inhibited
in both cases, and the rate of tumor formation and growth in male athymic n
ude mice injected with M12asBP4 was markedly reduced relative to that in mi
ce receiving M12 control cells. Apoptosis induced by the topoisomerase inhi
bitor etoposide was also enhanced in transfected cells. The effects on colo
ny formation in soft agar and tumor formation in mice were maintained for t
he duration of the experiments, in contrast to the delayed growth observed
in the previous study of IGFBP-4 overexpression. A significant difference w
as found in the patterns of IGFBP expression; production of both messenger
RNA and protein for IGFBP-3 and IGFBP-6 was greatly increased in the M12asB
P4 and ALVA31asBP4 cell lines. Up-regulation of these binding proteins has
been observed in association with actions of 1,25-dihydroxyvitamin D-3 in p
rostate cancer cells, and the data suggest a role for IGFBP-3 and IGFBP-6 i
n the suppression of prostate tumor cell growth.